TGF-β and IDO have been implicated in Sertoli cell protection of transplanted syngeneic islets and reversal of diabetes in autoimmune non-obese diabetic (model of type 1 diabetes) mice, respectively (101). This evidence concerns the gene IDO1 and type 1 diabetes mellitus.